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detector volume. Narrow field photon beam data with the W1 
detector were compared to the data measured with other small field 
detectors, including diodes and micro ion chambers. 
Results: The scintillator response remained linear within 0.2% at the 
highest dose rate of 2400 MU/min. Dose rate response of the W1 
detector tracked that of a Famer chamber to within 0.5% when the 
instantaneous dose rate was varied by a factor of five with varying 
detector to source distance. The energy dependence of the 
scintillator response was within the measurement uncertainty of 0.5% 
when the dose in the sensitive region of the detector was referenced 
to that measured by an ADCL calibrated farmer chamber in water. 
Both 6MV and 10MV FFF beam depth dose measurements for 3x3 cm 
and 10x10 cm field sizes with the W1 detector agreed with the 
standard scanning ion chamber data within 0.6% beyond the build-up 
region down to 30 cm depth in water. Total output factors were in 
agreement with the diode and micro ion chamber results within 0.5% 
except at the smallest field of 0.5x0.5 cm, where the discrepancies of 
2-3% were attributed to the non-water equivalence of diode and steel 
central electrode of the ion chamber response. There were no 
significant differences in the scintillator response between the 
parallel and perpendicular orientations to the beam axis except at the 
smallest field sizeof 0.5x0.5cm where the longitudinal size (3mm) of 
the scintillator became comparable to the field size when placed 
perpendicularly to the beam axis. 
Conclusions: The newly available W1 scintillator provides a robust and 
reliable dosimetry system for most challenging small field photon 
beam measurements suitable for accurate stereotactic beam 
commissioning work. 
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Purpose/Objective: In vivo dosimetry is a reliable method to compare 
planned and delivered dose distributions, representing therefore a 
valid tool to systematically verify treatment accuracy and improve 
radiotherapy quality control. In this work, a specific type of MOSFET 
dosimeter called 'MOSkin' was studied to perform in vivo dosimetry in 
high dose rate (HDR) prostate BT. Urethral dose measurements were 
performed with MOSkins, both in single and in dual-MOSkin 
configuration, in a tissue-equivalent phantom reproducing a typical 
prostate BT implant. Obtained data were compared to dose values 
calculated by the Treatment Planning System (TPS). 
Materials and Methods: The design of the MOSkin dosimeter is 
optimized to measure dose in steep dose gradients. Different from 
other commercial MOSFETs, MOSkins are placed within a thin kapton 
layer and hermetically sealed with water-equivalent flexible carrier of 
reproducible thickness. The sensitive volume, defined by the volume 
of the gate oxide, is 4.8 x 10-6 mm3 only. MOSkin detectors have 
shown good characteristics of reproducibility and linearity. 
Experiments performed with the 192Ir source of a HDR brachytherapy 
facility have shown negligible energy response for photons from the Ir-
192 source. Angular response is within the experimental error when 
using the dual-MOSkin configuration. 
In this work, a typical prostate implant with 14 interstitial needles 
and one urethral catheter was realized inside a tissue-equivalent 
cylindrical gel phantom. CT imaging was performed in order to 
precisely localize needles and the urethral catheter and to plan a 
treatment. MOSkin detectors, which were placed in the urethral 
catheter before imaging, were accurately recognized as small 
radiopaque spots. A series of measurements with the same irradiation 
set-up were performed with different dose prescriptions according to 
different developed treatment plans. The cumulative urethral doses 
measured with the single or dual-MOSkin detector were compared to 
the doses calculated by the TPS in the same points. Moreover, the 
contributions to the cumulative dose given by the source moving in 
each single needle were calculated separately and compared to the 
measured ones. 
Results: Comparison of cumulative dose to the urethra measured with 
the single or the dual-MOSkin detectors and the dose calculated by 
the TPS in the same points is reported in Table 1. Measurements were 
repeated for several different treatment plans with different dose 
prescriptions. Results were compared to the dose values calculated by 
the TPS and the highest discrepancies were found to be within 8% and 
3.8% for single and dual-MOSkin detectors, respectively. 
  
Conclusions: MOSkin detectors can be profitably utilized for real-time 
in vivo dosimetry during HDR prostate brachytherapy treatments. The 
dual-MOSkin configuration provides greater accuracy than the single 
MOSkin detector, as angular isotropy is in the first case greatly 
improved. 
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Purpose/Objective: To characterize the newly discovered 
temperature dependence of plastic scintillation detectors (PSDs) 
constructed from BCF-60 and BCF-12 scintillating fibers coupled to 
plastic optical fiber with cyanoacrylate. 
Materials and Methods: PSDs were constructed by optically coupling 2 
mm of scintillating fiber to clear plastic optical fiber with 
cyanoacrylate. Black polyethylene jacketing enclosed the fibers to 
prevent admission of external light. The detectors were calibrated on 
a Cobalt unit using the chromatic removal technique. The detectors 
were immersed in a water bath and irradiated at different 
temperatures ranging from 15 oC to 40 oC, holding all other conditions 
constant. Prior to each irradiation the temperature of the water bath 
was held constant for at least 10 minutes to ensure that the detectors 
and water were in thermal equilibrium. An Andor Luca S CCD camera 
was used to quantify changes in dose measured by the detectors. An 
Andor spectrometer was used to quantify changes in the spectral 
intensity and distribution of different detectors' outputs including a 
detector without scintillating fiber(to isolate temperature effects of 
the production of Cerenkov light by the detector), BCF-60 and BCF-12 
detectors, and a detector with an isolated optical coupling. The latter 
consisted of a BCF-60 detector that was cut two meters below the 
scintillating element and reattached with cyanoacrylate. Only this 
isolated coupling was placed in the water bath while the active 
volume was maintained at room temperature and irradiated to 
produce light. This enabled characterization of the temperature 
dependence of light transmission through a cyanoacrylate coupling. 
Results: BCF-60 and BCF-12 detectors respectively exhibited a 0.50% 
and 0.09% average decrease in measured dose relative to room 
temperature per oC increase in temperature. Results for a pair of BCF-
60 and a pair of BCF-12 detectors are plotted in Figure 1. 
 
Spectrometry demonstrated that the Cerenkov output and the 
transmission of the optical fiber are independent of temperature 
